Akihiro Katayama

1.3k citations

19 papers · 1.0k indexed · h-index 17

Co-authors: Jun Eguchi Atsuko Nakatsuka Jun Wada Kazutoshi Murakami Sanae Teshigawara Hirofumi Makino Motoko Kanzaki Yasuaki Harabuchi
Topics: Endoplasmic Reticulum Stress and Disease (4 papers)MicroRNA in disease regulation (4 papers)Adipose Tissue and Metabolism (3 papers)
Cited by: Cancer Research Immunology Otorhinolaryngology
Journals: PLoS ONE Circulation Research The Journal of Clinical Endocrinology & Metabolism
Partner nations: Japan Canada

In The Last Decade

Akihiro Katayama

19 papers receiving 1.0k citations

Peers

Countries citing papers authored by Akihiro Katayama

Since Specialization

Citations

This map shows the geographic impact of Akihiro Katayama's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Akihiro Katayama with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Akihiro Katayama more than expected).

Fields of papers citing papers by Akihiro Katayama

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Akihiro Katayama. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Akihiro Katayama. The network helps show where Akihiro Katayama may publish in the future.

Co-authorship network of co-authors of Akihiro Katayama

This figure shows the co-authorship network connecting the top 25 collaborators of Akihiro Katayama. A scholar is included among the top collaborators of Akihiro Katayama based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Akihiro Katayama. Akihiro Katayama is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

#	Work	Indexed citations
1	Adipocyte-Specific Inhibition of Mir221/222 Ameliorates Diet-Induced Obesity Through Targeting Ddit4 2022 ·Frontiers in Endocrinology ·Satoshi Yamaguchi,(unknown),Akihiro Katayama,(unknown),(unknown),(unknown),Atsuko Nakatsuka,Jun Eguchi,Jun Wada	17
2	Insufficiency of phosphatidylethanolamine N-methyltransferase is risk for lean non-alcoholic steatohepatitis 2016 ·Scientific Reports ·Atsuko Nakatsuka,Makoto Matsuyama,Satoshi Yamaguchi,Akihiro Katayama,Jun Eguchi,Kazutoshi Murakami,Sanae Teshigawara,Daisuke Ogawa,Nozomu Wada,Tetsuya Yasunaka,Fusao Ikeda,Akinobu Takaki,Eijiro Watanabe,Jun Wada	46
3	Antiobesity Action of ACAM by Modulating the Dynamics of Cell Adhesion and Actin Polymerization in Adipocytes 2016 ·Diabetes ·Kazutoshi Murakami,Jun Eguchi,Kazuyuki Hida,Atsuko Nakatsuka,Akihiro Katayama,(unknown),(unknown),(unknown),Daisuke Ogawa,Kohji Takei,Fumio Otsuka,Jun Wada	16
4	Translocase of inner mitochondrial membrane 44 alters the mitochondrial fusion and fission dynamics and protects from type 2 diabetes 2015 ·Metabolism ·(unknown),Akihiro Katayama,Takahiro Terami,Xiaoying Han,Tomokazu Nunoue,(unknown),Sanae Teshigawara,Jun Eguchi,Atsuko Nakatsuka,Kazutoshi Murakami,Daisuke Ogawa,Yasuhide Furuta,Hirofumi Makino,Jun Wada	21
5	Beneficial impact of Gpnmb and its significance as a biomarker in nonalcoholic steatohepatitis 2015 ·Scientific Reports ·Akihiro Katayama,Atsuko Nakatsuka,Jun Eguchi,Kazutoshi Murakami,Sanae Teshigawara,Motoko Kanzaki,Tomokazu Nunoue,Kazuyuki Hida,Nozomu Wada,Tetsuya Yasunaka,Fusao Ikeda,Akinobu Takaki,Kazuhide Yamamoto,Hiroshi Kiyonari,Hirofumi Makino,Jun Wada	62
6	Pemt Deficiency Ameliorates Endoplasmic Reticulum Stress in Diabetic Nephropathy 2014 ·PLoS ONE ·Mayu Watanabe,Atsuko Nakatsuka,Kazutoshi Murakami,Kentaro Inoue,Takahiro Terami,(unknown),Akihiro Katayama,Sanae Teshigawara,Jun Eguchi,Daisuke Ogawa,Eijiro Watanabe,Jun Wada,Hirofumi Makino	20
7	Identification of Circulating miR-101, miR-375 and miR-802 as Biomarkers for Type 2 Diabetes 2014 ·Metabolism ·(unknown),Atsuko Nakatsuka,Jun Eguchi,Sanae Teshigawara,Motoko Kanzaki,Akihiro Katayama,Satoshi Yamaguchi,Naoto Takahashi,Kazutoshi Murakami,Daisuke Ogawa,(unknown),Hirofumi Makino,Jun Wada	143
8	Serum galectin-9 levels are elevated in the patients with type 2 diabetes and chronic kidney disease 2013 ·BMC Nephrology ·(unknown),Jun Wada,Motoko Kanzaki,Sanae Teshigawara,Atsuko Nakatsuka,Kazutoshi Murakami,Kentaro Inoue,Takahiro Terami,Akihiro Katayama,Mayu Watanabe,(unknown),Jun Eguchi,Nobuyuki Miyatake,Hirofumi Makino	52
9	Urinary Fetuin-A Is a Novel Marker for Diabetic Nephropathy in Type 2 Diabetes Identified by Lectin Microarray 2013 ·PLoS ONE ·Kentaro Inoue,Jun Wada,Jun Eguchi,Atsuko Nakatsuka,Sanae Teshigawara,Kazutoshi Murakami,Daisuke Ogawa,Takahiro Terami,Akihiro Katayama,Atsuhito Tone,Izumi Iseda,Kazuyuki Hida,Masao Yamada,Tomohisa Ogawa,Hirofumi Makino	49
10	Visceral Adipose Tissue-derived Serine Proteinase Inhibitor Inhibits Apoptosis of Endothelial Cells as a Ligand for the Cell-Surface GRP78/Voltage-dependent Anion Channel Complex 2013 ·Circulation Research ·Atsuko Nakatsuka,Jun Wada,Izumi Iseda,Sanae Teshigawara,Kanji Higashio,Kazutoshi Murakami,Motoko Kanzaki,Kentaro Inoue,Takahiro Terami,Akihiro Katayama,Kazuyuki Hida,Jun Eguchi,Daisuke Ogawa,Yasushi Matsuki,Ryuji Hiramatsu,Hideo Yagita∥,Shigeru Kakuta,Yoichiro Iwakura,Hirofumi Makino	72
11	A Case of Type 2 Diabetes and Metastatic Liver Cancer Exhibiting Hypercholesterolemia with Abnormal Lipoproteins 2012 ·Internal Medicine ·Motoko Kanzaki,Jun Wada,Atsuko Nakatsuka,Sanae Teshigawara,Kazutoshi Murakami,Kentaro Inoue,Takahiro Terami,Akihiro Katayama,Junichiro Nasu,Kazuhide Yamamoto,Hirofumi Makino	1
12	Peritoneovenous shunting for refractory ascites results in worsening of nephrotic syndrome 2012 ·Hepatology Research ·Akinobu Takaki,Yohei Maeshima,Takahito Yagi,Akihiro Katayama,(unknown),Shigeru Akagi,Hitoshi Sugiyama,Takeshi Tomoda,Yoshiaki Iwasaki,Tetsuya Yasunaka,Fusao Ikeda,Yasuhiro Miyake,Haruhiko Kobashi,Atsushi Hirano,Hirofumi Makino,Kazuhide Yamamoto	1
13	Serum Vaspin Concentrations Are Closely Related to Insulin Resistance, and rs77060950 atSERPINA12Genetically Defines Distinct Group with Higher Serum Levels in Japanese Population 2012 ·The Journal of Clinical Endocrinology & Metabolism ·Sanae Teshigawara,Jun Wada,Kazuyuki Hida,Atsuko Nakatsuka,Jun Eguchi,Kazutoshi Murakami,Motoko Kanzaki,Kentaro Inoue,Takahiro Terami,Akihiro Katayama,Izumi Iseda,Yuichi Matsushita,Nobuyuki Miyatake,John F. McDonald,Kikuko Hotta,Hirofumi Makino	56
14	Vaspin Is an Adipokine Ameliorating ER Stress in Obesity as a Ligand for Cell-Surface GRP78/MTJ-1 Complex 2012 ·Diabetes ·Atsuko Nakatsuka,Jun Wada,Izumi Iseda,Sanae Teshigawara,Kanji Higashio,Kazutoshi Murakami,Motoko Kanzaki,Kentaro Inoue,Takahiro Terami,Akihiro Katayama,Kazuyuki Hida,Jun Eguchi,(unknown),Daisuke Ogawa,Yasushi Matsuki,Ryuji Hiramatsu,Hideo Yagita∥,Shigeru Kakuta,Yoichiro Iwakura,Hirofumi Makino	108
15	Tumour suppressive microRNA-874 regulates novel cancer networks in maxillary sinus squamous cell carcinoma 2011 ·British Journal of Cancer ·Nijiro Nohata,Toyoyuki Hanazawa,Naoko Kikkawa,Daiju Sakurai,Lisa Fujimura,Takeshi Chiyomaru,Kazumori Kawakami,Hirofumi Yoshino,Hideki Enokida,Masayuki Nakagawa,Akihiro Katayama,Yasuaki Harabuchi,Yoshitaka Okamoto,Naohiko Seki	81
16	RXR antagonism induces G₀/G₁ cell cycle arrest and ameliorates obesity by up‐regulating the p53–p21$^{\rm{Cip1}}$ pathway in adipocytes 2011 ·The Journal of Pathology ·Atsuko Nakatsuka,Jun Wada,Kazuyuki Hida,(unknown),Jun Eguchi,Sanae Teshigawara,Kazutoshi Murakami,Motoko Kanzaki,Kentaro Inoue,Takahiro Terami,Akihiro Katayama,Daisuke Ogawa,Hiroyuki Kagechika,Hirofumi Makino	21
17	Galectin-9 and T Cell Immunoglobulin Mucin-3 Pathway Is a Therapeutic Target for Type 1 Diabetes 2011 ·Endocrinology ·Motoko Kanzaki,Jun Wada,Koichi Sugiyama,Atsuko Nakatsuka,Sanae Teshigawara,Kazutoshi Murakami,Kentaro Inoue,Takahiro Terami,Akihiro Katayama,Jun Eguchi,Hisaya Akiba,Hideo Yagita∥,Hirofumi Makino	73
18	Inducible nitric oxide synthase expression in various laryngeal lesions in relation to carcinogenesis, angiogenesis, and patients’ prognosis 2007 ·Acta Oto-Laryngologica ·(unknown),Satoshi Nonaka,Akihiro Katada,Nobuyuki Bandoh,Takeshi Ogino,Akihiro Katayama,Miki Takahara,Tatsuya Hayashi,Yasuaki Harabuchi	16
19	Expressions of Matrix Metalloproteinases in Early-Stage Oral Squamous Cell Carcinoma as Predictive Indicators for Tumor Metastases and Prognosis 2004 ·Clinical Cancer Research ·Akihiro Katayama,Nobuyuki Bandoh,Kan Kishibe,Miki Takahara,Takeshi Ogino,Satoshi Nonaka,Yasuaki Harabuchi	176

About Akihiro Katayama

Akihiro Katayama is a scholar working on Aging, Cancer Research and Clinical Biochemistry, having authored 19 papers that have together received 1.0k indexed citations. Recurring topics across this work include Endoplasmic Reticulum Stress and Disease (4 papers), MicroRNA in disease regulation (4 papers) and Adipose Tissue and Metabolism (3 papers). The work is most often cited by research in Cancer Research (368 citations), Immunology (177 citations) and Otorhinolaryngology (35 citations). Akihiro Katayama has collaborated with scholars based in Japan and Canada. Frequent co-authors include Jun Eguchi, Atsuko Nakatsuka, Jun Wada, Kazutoshi Murakami, Sanae Teshigawara, Hirofumi Makino, Motoko Kanzaki, Yasuaki Harabuchi, Takahiro Terami and Nobuyuki Bandoh. Their work appears in journals such as PLoS ONE, Circulation Research and The Journal of Clinical Endocrinology & Metabolism.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact